Martin Price - Leading the HealthTrackRx Lab’s Pandemic Response

As the executive chairman of HealthTrackRx, Martin Price runs a national clinical laboratory committed to antibiotic stewardship and infectious disease testing. Since the beginning of the COVID-19 health crisis, Martin Price has overseen the rapid expansion of laboratory programming in which HealthTrackRx restructured its executive team and doubled its total staff.

In addition to leading more than 600 employees, Mr. Price is responsible for implementing strategies to achieve time-sensitive objectives, such as increasing the company's throughput by a factor of 50. Under his leadership, the laboratory now has the capability to conduct nearly 1 million PCR tests monthly to aid in the global response to the pandemic.

In addition to this position, Martin Price is the president of the Annalex Group, an advisory firm headquartered in Washington, D.C. Working with investors, the board of directors, and management professionals, he utilizes his background in the field of law to assist businesses in areas such as litigation, restructuring, and corporate turnaround.

Among his accreditations, he received a juris doctor from the George Washington University Law School. He also holds a master's in economics from Duke University, where his thesis focused on the repercussions of Paul Krugman's 45-degree rule across industrial economies.